Monday, October 6, 2025

Latest

Columbia Care To Raise $130.0 Million Via Bought Deal Financing

Columbia Care (CSE: CCHW) (NEO: CCHW) is the latest US multi state operator to announce a financing following the election results south of the border. The company late last night announced that it will be conducting a bought deal financing to the tune of C$130.0 million.

The bought deal financing will see the company sell 16.2 million common shares of the company, at a price of $8.05 per share. No warrants are being included under the offering. An over-allotment option has been granted to the underwriters, enabling the financing to be expanded by up to 15% for a period of thirty days following the close of the financing.

Gross proceeds from the financing are to be used for working capital and general corporate purposes.

The financing is currently expected to close by January 13, 2021.

Columbia Care last traded at $8.77 on the CSE.


Information for this briefing was found via Sedar and Columbia Care Inc. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

Cresco Labs To Pay US$2.0 Billion In Stock To Acquire Columbia Care

Consolidation within the US cannabis space continued this morning with the proposed combination of Columbia...

Wednesday, March 23, 2022, 07:58:57 AM

Columbia Care Posts Q4 Revenues Of $139.3 Million, Net Loss

Columbia Care (NEO: CCHW) this morning reported its fourth quarter and full year financial results,...

Thursday, March 24, 2022, 09:21:13 AM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Haywood Cuts Cresco Labs Price Target To $15.50 On Poor Earnings

At the tail end of March, Cresco Labs (CSE: CL) announced its fourth-quarter financial results,...

Sunday, April 3, 2022, 03:09:00 PM

PI Financial Names Columbia Care, Red White & Bloom As Top Picks For 2021

PI Financial released their top picks for 2021 today. Within, they named Columbia Care (CSE:...

Tuesday, January 19, 2021, 05:05:00 PM